Prospective Assessment of Procedure-Related and Patient-Reported Outcomes After Retrograde Intrarenal Surgery (RIRS) for Renal Calculi Less Than 20 mm
Launched by MANSOURA UNIVERSITY · Oct 24, 2018
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Ability to give informed consent.
- 2. Stone criteria:
- • Less than 20 mm.
- • Infectious stone.
- • Growing stone on follow-up.
- 3. Kidney criteria:
- • Obstructing stone causing hydronephrosis.
- • Solitary kidney or bilateral renal stones.
- 4. Patients criteria:
- • Age ≥18 years.
- • Symptomatic stone causing pain or hematuria.
- • Patient comorbidity omitting other modalities as bleeding diathesis or skeletal deformities.
- • Patient preference or patients' social situation concerning profession or amount of travel
- Exclusion Criteria:
- • 1. Inability to give informed consent.
- 2. Stone criteria:
- • More than 20 mm.
- • Peripheral calyceal asymptomatic stone static in size on follow-up.
- • Unsuitable/failure of initial treatment modalities (oral dissolution therapy-SWL) for stones less than 20 mm.
About Mansoura University
Mansoura University is a prestigious academic institution located in Egypt, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, it leverages its extensive resources and expertise in various fields of healthcare to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a network of healthcare professionals and researchers to conduct high-quality clinical trials, focusing on addressing critical health challenges through rigorous scientific methodologies. Its dedication to ethical research practices and adherence to regulatory standards underscores its role as a leader in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mansourah, Dk, Egypt
Al Manşūrah, , Egypt
Patients applied
Trial Officials
Amr A Elsawy, MD
Principal Investigator
Urology and Nephrology Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials